L & S Advisors Inc Bristol Myers Squibb CO Transaction History

L & S Advisors Inc

$832 Million
Q3 2024

A detailed history of L & S Advisors Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, L & S Advisors Inc holds 4,463 shares of BMY stock, worth $257,782. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,463

Holding current value

$257,782

% of portfolio

0.03%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$39.66 - $51.75 $177,002 - $230,960	4,463 New	4,463 $230,000
Q1 2024 May 10, 2024	BUY	$47.98 - $54.4 $181,364 - $205,632	3,780 New	3,780 $204,000
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $57,890 - $64,730	-1,000 Reduced 20.92%	3,780 $219,000
Q1 2023 May 10, 2023	SELL	$65.71 - $74.53 $4.51 Million - $5.12 Million	-68,668 Reduced 93.49%	4,780 $331,000
Q4 2022 Feb 13, 2023	SELL	$68.48 - $81.09 $1.26 Million - $1.49 Million	-18,339 Reduced 19.98%	73,448 $5.28 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $2,712 - $1.6 Million	20,866 Added 29.42%	91,787 $6.53 Million
Q2 2022 Aug 12, 2022	BUY	$72.62 - $79.98 $4.81 Million - $5.3 Million	66,216 Added 1407.35%	70,921 $5.46 Million
Q1 2022 May 11, 2022	SELL	$61.48 - $73.72 $76,358 - $91,560	-1,242 Reduced 20.88%	4,705 $344,000
Q4 2021 Feb 09, 2022	SELL	$53.63 - $62.52 $10,028 - $11,691	-187 Reduced 3.05%	5,947 $371,000
Q1 2021 May 10, 2021	SELL	$59.34 - $66.74 $1.64 Million - $1.84 Million	-27,598 Reduced 81.82%	6,134 $387,000
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $462,093 - $523,636	8,003 Added 31.1%	33,732 $2.09 Million
Q3 2020 Nov 13, 2020	SELL	$57.43 - $63.64 $817,228 - $905,597	-14,230 Reduced 35.61%	25,729 $1.55 Million
Q2 2020 Aug 13, 2020	SELL	$54.82 - $64.09 $347,010 - $405,689	-6,330 Reduced 13.67%	39,959 $2.35 Million
Q1 2020 May 13, 2020	SELL	$46.4 - $67.43 $20,787 - $30,208	-448 Reduced 0.96%	46,289 $2.58 Million
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $2.02 Million - $2.64 Million	41,115 Added 731.32%	46,737 $3 Million
Q1 2019 May 14, 2019	SELL	$45.12 - $53.8 $586 - $699	-13 Reduced 0.23%	5,622 $268,000
Q4 2017 Feb 14, 2018	SELL	$59.94 - $65.35 $59,940 - $65,349	-1,000 Reduced 15.07%	5,635 $345,000
Q3 2017 Nov 14, 2017	BUY	$55.23 - $63.74 $33,138 - $38,244	600 Added 9.94%	6,635 $423,000
Q2 2017 Aug 14, 2017	BUY	N/A	6,035	6,035 $336,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

Vanguard Group Inc Valley Forge, PA

189M
Shares

$10.9 Billion
0.18% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$9.16 Billion
0.15% of portfolio
State Street Corp Boston, MA

92.9M
Shares

$5.37 Billion
0.2% of portfolio
Jpmorgan Chase & CO New York, NY

77.9M
Shares

$4.5 Billion
0.33% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

61M
Shares

$3.53 Billion
0.61% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of L & S Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on L & S Advisors Inc with notifications on news.

Account